Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
azd1656 (1 trial)
hx009 (1 trial)
lm-061 (1 trial)
Neoplasms (Phase 1)
Trials (3 total)
Trial APIs (3 total)